$MU
Micron Technology Inc Stock $mu

$mu Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000072312518000156 Filed on December 19, 2018

Income Statement

Concept	2018 Q4	2017 Q4
Revenue	$7.913B	$6.803B
YoY Change	16.32%	71.36%
Cost Of Revenue	$3.298B	$3.056B
YoY Change	7.92%	3.28%
Gross Profit	$4.615B	$3.747B
YoY Change	23.17%	270.62%
Gross Profit Margin	58.32%	55.08%
Selling, General & Admin	$209.0M	$191.0M
YoY Change	9.42%	20.13%
% of Gross Profit	4.53%	5.1%
Research & Development	$611.0M	$448.0M
YoY Change	36.38%	-4.68%
% of Gross Profit	13.24%	11.96%
Depreciation & Amortization	$1.335B	$1.090B
YoY Change	22.48%	46.51%
% of Gross Profit	28.93%	29.09%
Operating Expenses	$820.0M	$639.0M
YoY Change	28.33%	1.59%
Operating Profit	$3.759B	$3.097B
YoY Change	21.38%	762.67%
Interest Expense	$33.00M	$124.0M
YoY Change	-73.39%	-10.79%
% of Operating Profit	0.88%	4.0%
Other Income/Expense, Net	$9.000M	-$204.0M
YoY Change	-104.41%	1357.14%
Pretax Income	$3.773B	$2.792B
YoY Change	35.14%	1210.8%
Income Tax	$477.0M	$114.0M
% Of Pretax Income	12.64%	4.08%
Net Earnings	$3.293B	$2.678B
YoY Change	22.96%	1387.78%
Net Earnings / Revenue	41.62%	39.36%
Basic Earnings Per Share	$2.91	$2.36
Diluted Earnings Per Share	$2.81	$2.19
COMMON SHARES
Basic Shares Outstanding	1.133B shares	1.134B shares
Diluted Shares Outstanding	1.174B shares	1.225B shares

Balance Sheet

Concept	2018 Q4	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.563B	$6.174B
YoY Change	-9.9%	48.09%
Cash & Equivalents	$4.447B	$6.008B
Short-Term Investments	$1.116B	$166.0M
Other Short-Term Assets	$182.0M	$148.0M
YoY Change	22.97%	12.12%
Inventory	$3.876B	$3.160B
Prepaid Expenses
Receivables	$4.980B	$3.603B
Other Receivables	$212.0M	$167.0M
Total Short-Term Assets	$15.04B	$13.36B
YoY Change	12.58%	40.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.81B	$20.72B
YoY Change	19.71%	35.26%
Goodwill	$1.228B	$1.228B
YoY Change	0.0%
Intangibles	$356.0M	$368.0M
YoY Change	-3.26%	-17.3%
Long-Term Investments	$1.565B	$314.0M
YoY Change	398.41%	-77.59%
Other Assets	$758.0M	$469.0M
YoY Change	61.62%	14.11%
Total Long-Term Assets	$29.56B	$23.83B
YoY Change	24.01%	30.01%
TOTAL ASSETS
Total Short-Term Assets	$15.04B	$13.36B
Total Long-Term Assets	$29.56B	$23.83B
Total Assets	$44.60B	$37.19B
YoY Change	19.91%	33.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.683B	$1.209B
YoY Change	39.21%	-7.29%
Accrued Expenses	$550.0M	$460.0M
YoY Change	19.57%	31.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$398.0M	$1.401B
YoY Change	-71.59%	21.3%
Total Short-Term Liabilities	$5.189B	$5.583B
YoY Change	-7.06%	0.67%
LONG-TERM LIABILITIES
Long-Term Debt	$3.736B	$7.662B
YoY Change	-51.24%	-10.08%
Other Long-Term Liabilities	$834.0M	$553.0M
YoY Change	50.81%	-7.99%
Total Long-Term Liabilities	$834.0M	$553.0M
YoY Change	50.81%	-7.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.189B	$5.583B
Total Long-Term Liabilities	$834.0M	$553.0M
Total Liabilities	$9.757B	$13.78B
YoY Change	-29.19%	-5.86%
SHAREHOLDERS EQUITY
Retained Earnings	$27.77B	$12.94B
YoY Change	114.63%	136.57%
Common Stock	$8.467B	$9.564B
YoY Change	-11.47%	21.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.87B	$22.53B
YoY Change
Total Liabilities & Shareholders Equity	$44.60B	$37.19B
YoY Change	19.91%	33.61%

Cashflow Statement

Concept	2018 Q4	2017 Q4
OPERATING ACTIVITIES
Net Income	$3.293B	$2.678B
YoY Change	22.96%	1387.78%
Depreciation, Depletion And Amortization	$1.335B	$1.090B
YoY Change	22.48%	46.51%
Cash From Operating Activities	$4.810B	$3.636B
YoY Change	32.29%	219.51%
INVESTING ACTIVITIES
Capital Expenditures	$2.700B	$1.956B
YoY Change	38.04%	54.75%
Acquisitions
YoY Change
Other Investing Activities	$53.00M	-$69.00M
YoY Change	-176.81%	527.27%
Cash From Investing Activities	-$4.427B	-$1.434B
YoY Change	208.72%	53.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.836B	-$1.337B
YoY Change	-237.32%	-10384.62%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.435B	-$1.282B
YoY Change	89.94%	504.72%
NET CHANGE
Cash From Operating Activities	$4.810B	$3.636B
Cash From Investing Activities	-$4.427B	-$1.434B
Cash From Financing Activities	-$2.435B	-$1.282B
Net Change In Cash	-$2.062B	$914.0M
YoY Change	-325.6%	-1857.69%
FREE CASH FLOW
Cash From Operating Activities	$4.810B	$3.636B
Capital Expenditures	$2.700B	$1.956B
Free Cash Flow	$2.110B	$1.680B
YoY Change	25.6%	-1433.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	51000000	USD
CY2018Q4	dei	Amendment Flag AmendmentFlag	false
CY2018Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-29
CY2018Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2018Q4	dei	Document Period End Date DocumentPeriodEndDate	2018-11-29
CY2018Q4	dei	Document Type DocumentType	10-Q
CY2018Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000723125
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1121046809	shares
CY2018Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q4	dei	Entity Registrant Name EntityRegistrantName	MICRON TECHNOLOGY INC
CY2018Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q3	mu	Equipment Purchase Payable Current EquipmentPurchasePayableCurrent	1238000000	USD
CY2018Q4	mu	Equipment Purchase Payable Current EquipmentPurchasePayableCurrent	1213000000	USD
CY2017Q4	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	-195000000	USD
CY2018Q4	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	14000000	USD
CY2017Q4	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	-5000000	USD
CY2018Q4	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	-3000000	USD
CY2017Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	133000000	USD
CY2018Q4	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	20000000	USD
CY2017Q4	mu	Proceeds From Government Incentives ProceedsFromGovernmentIncentives	0	USD
CY2018Q4	mu	Proceeds From Government Incentives ProceedsFromGovernmentIncentives	236000000	USD
CY2017Q4	mu	Reclassification Adjustment For Convertible Debt In Mezzanine ReclassificationAdjustmentForConvertibleDebtInMezzanine	-3000000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6506000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4447000000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5216000000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6130000000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	61000000	USD
CY2017Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	29000000	USD
CY2018Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	18000000	USD
CY2017Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2018Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6000000	shares
CY2018Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	16000000	USD
CY2018Q3	us-gaap	Assets Assets	43376000000	USD
CY2018Q4	us-gaap	Assets Assets	44595000000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	16039000000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	15039000000	USD
CY2018Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	7275000000	USD
CY2018Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	7128000000	USD
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2018Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	296000000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6587000000	USD
CY2018Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1116000000	USD
CY2017Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3056000000	USD
CY2018Q3	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	92000000	USD
CY2018Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	4636000000	USD
CY2018Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	4132000000	USD
CY2018Q3	us-gaap	Debt Current DebtCurrent	859000000	USD
CY2018Q4	us-gaap	Debt Current DebtCurrent	398000000	USD
CY2018Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	473000000	USD
CY2018Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	1565000000	USD
CY2017Q4	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	26000000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10000000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5000000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8201000000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8350000000	USD
CY2018Q4	mu	Reclassification Adjustment For Convertible Debt In Mezzanine ReclassificationAdjustmentForConvertibleDebtInMezzanine	-1000000	USD
CY2017Q4	mu	Tax Cutsand Jobs Act Measurement Period Adjustment Income Tax Expense Benefit TaxCutsandJobsActMeasurementPeriodAdjustmentIncomeTaxExpenseBenefit	0	USD
CY2018Q4	mu	Tax Cutsand Jobs Act Measurement Period Adjustment Income Tax Expense Benefit TaxCutsandJobsActMeasurementPeriodAdjustmentIncomeTaxExpenseBenefit	47000000	USD
CY2018Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4374000000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4200000000	USD
CY2018Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	201000000	USD
CY2018Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	185000000	USD
CY2018Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1692000000	USD
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1683000000	USD
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	271000000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	36000000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5056000000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4980000000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25419000000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26396000000	USD
CY2018Q4	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	52000000	USD
CY2018Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1022000000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	842000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4525000000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	914000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2062000000	USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1170000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1172000000	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1161000000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1120000000	shares
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	117000000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	117000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2673000000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3278000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3298000000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2673000000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3281000000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	298000000	USD
CY2018Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	348000000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	67000000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	117000000	USD
CY2018Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	332000000	USD
CY2018Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	986000000	USD
CY2017Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1090000000	USD
CY2018Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1335000000	USD
CY2018Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	190000000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	64000000	USD
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.36
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.91
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.19
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.81
CY2017Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6000000	USD
CY2018Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-10000000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	841000000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	550000000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	498000000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M
CY2017Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	57000000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	23000000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	344000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	357000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	55000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	40000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	47000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	58000000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	64000000	USD
CY2017Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9000000	USD
CY2018Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5000000	USD
CY2017Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-195000000	USD
CY2018Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14000000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	1228000000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	1228000000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	3747000000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	4615000000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2792000000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3773000000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114000000	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	477000000	USD
CY2017Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	391000000	USD
CY2018Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	427000000	USD
CY2017Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.32
CY2018Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.36
CY2018Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	161000000	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	226000000	USD
CY2017Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-230000000	USD
CY2018Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-46000000	USD
CY2017Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-37000000	USD
CY2018Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-192000000	USD
CY2017Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	37000000	USD
CY2018Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	286000000	USD
CY2017Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	121000000	USD
CY2018Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-189000000	USD
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	675000000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	713000000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	331000000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	356000000	USD
CY2017Q4	us-gaap	Interest Expense InterestExpense	124000000	USD
CY2018Q4	us-gaap	Interest Expense InterestExpense	33000000	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	815000000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	745000000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	3595000000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	3876000000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	3590000000	USD
CY2018Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	423000000	USD
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	488000000	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2357000000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2643000000	USD
CY2017Q4	us-gaap	Investment Income Net InvestmentIncomeNet	23000000	USD
CY2018Q4	us-gaap	Investment Income Net InvestmentIncomeNet	38000000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	10112000000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	9757000000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43376000000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44595000000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5754000000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5189000000	USD
CY2018Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3777000000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3734000000	USD
CY2018Q3	us-gaap	Minority Interest MinorityInterest	870000000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	870000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1282000000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2435000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1434000000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4427000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3636000000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4810000000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	2678000000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	3293000000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2018Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	2678000000	USD
CY2018Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	3293000000	USD
CY2018Q4	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	3293000000	USD
CY2017Q4	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	18000000	USD
CY2018Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	3097000000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	3759000000	USD
CY2018Q3	us-gaap	Other Assets Current OtherAssetsCurrent	164000000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	182000000	USD
CY2018Q3	us-gaap	Other Assets Current OtherAssetsCurrent	180000000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	611000000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	758000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-3000000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-12000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5000000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1000000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	521000000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	591000000	USD
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	517000000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	581000000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	834000000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	582000000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-204000000	USD
CY2018Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000000	USD
CY2017Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-56000000	USD
CY2018Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	65000000	USD
CY2017Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-11000000	USD
CY2018Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-36000000	USD
CY2018Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	261000000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	212000000	USD
CY2017Q4	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	88000000	USD
CY2018Q4	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	378000000	USD
CY2017Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-69000000	USD
CY2018Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	53000000	USD
CY2017Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	23000000	USD
CY2018Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1836000000	USD
CY2017Q4	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	186000000	USD
CY2018Q4	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2047000000	USD
CY2017Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1956000000	USD
CY2018Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2700000000	USD
CY2017Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	150000000	USD
CY2018Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2017Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1472000000	USD
CY2018Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	15000000	USD
CY2017Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	85000000	USD
CY2018Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	60000000	USD
CY2017Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4000000	USD
CY2018Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-17000000	USD
CY2017Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	554000000	USD
CY2018Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	77000000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	2678000000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	3296000000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49091000000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	51203000000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23672000000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24807000000	USD
CY2018Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	5478000000	USD
CY2018Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	5418000000	USD
CY2018Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	5592000000	USD
CY2018Q3	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	97000000	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	97000000	USD
CY2017Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	2744000000	USD
CY2018Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	577000000	USD
CY2017Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	448000000	USD
CY2018Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	611000000	USD
CY2018Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	81000000	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	78000000	USD
CY2018Q4	us-gaap	Restructuring Charges RestructuringCharges	16000000	USD
CY2017Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	6000000	USD
CY2018Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	33000000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	24395000000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	27769000000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	24487000000	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6803000000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7913000000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	191000000	USD
CY2018Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	209000000	USD
CY2017Q4	us-gaap	Share Based Compensation ShareBasedCompensation	51000000	USD
CY2018Q4	us-gaap	Share Based Compensation ShareBasedCompensation	61000000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed	Black-Scholes
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	115000000	shares
CY2017Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1366000000	USD
CY2017Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	106000000	USD
CY2018Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	32294000000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	33869000000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19470000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23393000000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33164000000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	569000000	USD
CY2018Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	3000000	USD
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2000000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34739000000	USD
CY2018Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	402000000	USD
CY2018Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9000000	shares
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	52000000	shares
CY2018Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	429000000	USD
CY2018Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2362000000	USD
CY2017Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	23000000	USD
CY2018Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1836000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268000000	USD
CY2018Q3	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Assets VariableInterestEntityNonconsolidatedCarryingAmountAssets	63000000	USD
CY2018Q4	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Assets VariableInterestEntityNonconsolidatedCarryingAmountAssets	61000000	USD
CY2018Q3	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Liabilities VariableInterestEntityNonconsolidatedCarryingAmountLiabilities	63000000	USD
CY2018Q4	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Liabilities VariableInterestEntityNonconsolidatedCarryingAmountLiabilities	60000000	USD
CY2017Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	91000000	shares
CY2018Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	41000000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1225000000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1174000000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1134000000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1133000000	shares
CY2018Q4	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 30, 2018, except for changes related to recently adopted accounting standards. See "Recently Adopted Accounting Standards" note. Prior year information is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2019 and 2018 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 30, 2018.</font></div></div>
CY2018Q4	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior year information is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards. </font></div></div>
CY2018Q4	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2018, the FASB issued ASU 2018-18 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Collaborative Arrangements</font><font style="font-family:inherit;font-size:10pt;">, which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue when the collaborative arrangement participant is a customer in the context of a unit of account and precludes recognizing as revenue consideration received from a collaborative arrangement participant if the participant is not a customer. This ASU will be effective for us in the first quarter of 2021 with early adoption permitted. This ASU requires retrospective adoption to the date we adopted ASC 606, August 31, 2018, by recognizing a cumulative-effect adjustment to the opening balance of retained earnings of the earliest annual period presented. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Measurement of Credit Losses on Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. This ASU will be effective for us in the first quarter of 2021 with adoption permitted as early as the first quarter of 2020. This ASU requires modified retrospective adoption, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of- use asset and corresponding liability, measured at the present value of lease payments. This ASU, as amended, will be effective for us in the first quarter of 2020 with early adoption permitted and allows for either a modified retrospective adoption or a retrospective adoption by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The adoption of this ASU will result in an increase to our consolidated balance sheets for these right-of-use assets and corresponding liabilities. We are evaluating the timing and other effects of our adoption of this ASU on our financial statements.</font></div></div>
CY2018Q4	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2019 and 2018 each contain 52 weeks. </font></div></div>
CY2018Q4	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron; Micron Semiconductor Products, Inc.; and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 15, 2014, Innovative Memory Solutions, Inc. ("IMS") filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe </font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents and seeks damages, attorneys' fees, and costs. On July 23, 2018, IMS served a patent infringement complaint on Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited alleging that products including our SSDs infringe a European patent. The complaint seeks unspecified damages and an order forbidding Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited from offering to sell, using, and importing the accused products. On August 31, 2018, Micron was served with a complaint filed by IMS in Shenzhen Intermediate People's Court in Guangdong Province, China. The complaint alleges that certain of our NAND flash products infringe a Chinese patent. The complaint seeks an order requiring Micron to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of </font><font style="font-family:inherit;font-size:10pt;">1 million</font><font style="font-family:inherit;font-size:10pt;"> Chinese yuan plus expenses.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 19, 2018, Micron Semiconductor (Xi’an) Co., Ltd. ("MXA") was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. ("Jinhua") in the Fuzhou Intermediate People’s Court in Fujian Province, China (the "Fuzhou Court"). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. ("MSS") was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of </font><font style="font-family:inherit;font-size:10pt;">98 million</font><font style="font-family:inherit;font-size:10pt;"> Chinese yuan plus court fees incurred.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation ("UMC") in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of </font><font style="font-family:inherit;font-size:10pt;">90 million</font><font style="font-family:inherit;font-size:10pt;"> Chinese yuan plus court fees incurred.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and two additional complaints filed by UMC in the Fuzhou Court. The three additional complaints allege that MSS infringes three Chinese patents by manufacturing and selling certain Crucial MX300 SSDs and certain GDDR5 memory chips. The two complaints filed by UMC each seek an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of </font><font style="font-family:inherit;font-size:10pt;">90 million</font><font style="font-family:inherit;font-size:10pt;"> Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of </font><font style="font-family:inherit;font-size:10pt;">98 million</font><font style="font-family:inherit;font-size:10pt;"> Chinese yuan plus court fees incurred. On October 9, 2018, UMC withdrew its complaint that alleged MSS infringed a Chinese patent by manufacturing and selling certain GDDR5 memory chips.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistic-branded DRAM modules and solid-state drives in China. The affected products make up slightly more than </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> of our annualized revenues. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for a significant portion of our revenue.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Qimonda</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda's insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera (the "Inotera Shares"), representing approximately </font><font style="font-family:inherit;font-size:10pt;">18%</font><font style="font-family:inherit;font-size:10pt;"> of Inotera's outstanding shares as of </font><font style="font-family:inherit;font-size:10pt;">November 29, 2018</font><font style="font-family:inherit;font-size:10pt;">, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately </font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation, or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Antitrust Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 27, 2018, a purported class-action lawsuit was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California asserting claims based on alleged price-fixing of DRAM products during the period from June 1, 2016 to February 1, 2018. Similar cases were subsequently filed in federal court in the United States, as well as in Canadian courts in Quebec, Montreal and Toronto, Ontario. The complaints seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief. We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss. The final resolution of these matters could result in significant liability and could have a material adverse effect on our business, results of operations, or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 15, 2018, the Chinese State Administration for Market Regulation ("SAMR") notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 5, 2017, Micron filed a complaint against UMC and Jinhua in the U.S. District Court for the Northern District of California. The complaint alleges that UMC and Jinhua violated the Defend Trade Secrets Act, the civil provisions of the Racketeer Influenced and Corrupt Organizations Act, and California's Uniform Trade Secrets Act by misappropriating Micron's trade secrets and other misconduct. Micron's complaint seeks damages, restitution, disgorgement of profits, injunctive relief, and other appropriate relief.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.</font></div></div>
CY2018Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation.</font></div></div>

Files In Submission

Name	View Source	Status
0000723125-18-000156-index-headers.html	Edgar Link	pending
0000723125-18-000156-index.html	Edgar Link	pending
0000723125-18-000156.txt	Edgar Link	pending
0000723125-18-000156-xbrl.zip	Edgar Link	pending
a2019q1.htm	Edgar Link	pending
a2019q1ex10-70xamendmentto.htm	Edgar Link	pending
a2019q1ex31-1xceocert.htm	Edgar Link	pending
a2019q1ex31-2xcfocert.htm	Edgar Link	pending
a2019q1ex32-1x906ceocert.htm	Edgar Link	pending
a2019q1ex32-2x906cfocert.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mu-20181129.xml	Edgar Link	completed
mu-20181129.xsd	Edgar Link	pending
mu-20181129_cal.xml	Edgar Link	unprocessable
mu-20181129_def.xml	Edgar Link	unprocessable
mu-20181129_lab.xml	Edgar Link	unprocessable
mu-20181129_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MU
Micron Technology Inc Stock $mu

2018 Q4 Form 10-Q Financial Statement

#000072312518000156 Filed on December 19, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU Micron Technology Inc Stock $mu

2018 Q4 Form 10-Q Financial Statement

#000072312518000156 Filed on December 19, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU
Micron Technology Inc Stock $mu